Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    "Leukoplakia"
Show Display Options
Rank Status Study
1 Terminated A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
Condition: Oral Leukoplakia
Intervention: Drug: Lozenge Intake
2 Completed Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
Condition: Oral Leukoplakia
Intervention: Procedure: photodynamic therapy
3 Completed Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
Condition: Oral Leukoplakia
Interventions: Drug: rosiglitazone maleate;   Other: laboratory biomarker analysis
4 Terminated Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
Condition: Oral Leukoplakia
Interventions: Drug: aminolevulinic acid hydrochloride;   Drug: photodynamic therapy;   Other: laboratory biomarker analysis
5 Completed Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)
Conditions: Leukoplakia, Hairy;   HIV Infections
Intervention: Drug: Acyclovir
6 Completed
Has Results
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Conditions: Head and Neck Cancer;   Oral Leukoplakia
Intervention: Drug: pioglitazone hydrochloride
7 Completed Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR
Conditions: Leukoplakia;   Periodontal Disease
Intervention: Drug: Ketorolac Rinse
8 Terminated
Has Results
Pioglitazone for Oral Premalignant Lesions
Condition: Oral Leukoplakia
Interventions: Drug: Pioglitazone hydrochloride;   Other: placebo;   Other: laboratory biomarker analysis
9 Completed
Has Results
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Conditions: Lip and Oral Cavity Cancer;   Oral Leukoplakia;   Oropharyngeal Cancer;   Tongue Cancer
Interventions: Drug: Bowman-Birk inhibitor concentrate;   Other: placebo;   Other: laboratory biomarker analysis
10 Recruiting Photodynamic Therapy for Oral Precursor Lesions
Conditions: Leukoplakia;   Lichen
Interventions: Other: Aminolaevulinic acid;   Other: Methylcellulose Placebo
11 Completed Fenretinide in Treating Patients With Leukoplakia of the Mouth
Condition: Head and Neck Cancer
Interventions: Drug: fenretinide;   Drug: Placebo
12 Completed Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Conditions: Head and Neck Cancer;   Precancerous Condition
Intervention: Drug: celecoxib
13 Completed Biomarkers for Oral Cancer
Conditions: Lichen Planus;   Oral Leukoplakia
Intervention:
14 Unknown  Least Invasive Nonlinear Light Microscopy
Conditions: Oral Leukoplakia;   Oral Cancer
Intervention:
15 Completed
Has Results
Treatment of Oral Premalignant Lesions With 5-ALA PDT
Conditions: Leukoplakia;   Erythroplakia
Interventions: Device: PDL-585, ScleroPLUS laser;   Drug: 5-Aminolevulinic Acid (Levulan KerastickTM);   Procedure: Fluorescence Diagnosis Imaging
16 Active, not recruiting A Randomized Study of Sulindac in Oral Premalignant Lesions
Conditions: Leukoplakia, Oral;   Benign Neoplasms
Interventions: Drug: sulindac;   Drug: Placebo
17 Completed Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
Condition: Precancerous Condition
Interventions: Drug: acetylsalicylic acid;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: biopsy
18 Unknown  Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity
Conditions: Squamous Cell Carcinoma of the Oral Cavity;   Leukoplakia Oral
Intervention: Procedure: contralateral healthy tissue biopsy
19 Withdrawn Natural History of Oro-pharyngeal Cancer Precursors
Conditions: Precancerous Conditions;   Leukoplakia;   Erythroplasia;   Oral Papillomas
Intervention:
20 Unknown  Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Condition: Head and Neck Cancer
Intervention: Drug: celecoxib

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.